Decreased expression of IL-17 pathway genes in blood in patients with plaque psoriasis treated with the anti-IL-17A monoclonal antibody, ixekizumab

被引：0
|
作者：
Krueger, J. G. [1 ]
Dow, E. R. [2 ]
Nantz, E. [2 ]
Komocsar, W. J. [2 ]
Banerjee, P. [2 ]
Leonardi, C. [3 ]
Cameron, G. S. [2 ]
Banerjee, S. [2 ]
Hoffman, R. W. [2 ]
机构：
[1] Rockefeller Univ, New York, NY 10021 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] St Louis Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2013年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
104
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [31] Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis
    Durham, L. E.
    Kirkham, B. W.
    Taams, L. S.
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (08)
  • [32] A Novel Monoclonal Antibody Specific to Mouse IL-17
    Yang, Jianjun
    Hong, Liu
    Wang, Weizhong
    Zhang, Hongwei
    HYBRIDOMA, 2011, 30 (03): : 287 - 289
  • [33] Anti-Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis REPLY
    Papp, Kim A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03): : 275 - 275
  • [34] Anti IL-17 flared psoriasis in a patient on secukinumab
    Noell, Claire
    McQuade, Brianna
    Gottlieb, Alice
    Rosmarin, David
    DERMATOLOGIC THERAPY, 2017, 30 (04)
  • [35] Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
    Hawkes, Jason E.
    Yan, Bernice Y.
    Chan, Tom C.
    Krueger, James G.
    JOURNAL OF IMMUNOLOGY, 2018, 201 (06): : 1605 - 1613
  • [36] The Anti-IL-17A Monoclonal Antibody Secukinumab (AIN457) Inhibits Pro-Inflammatory Mediator Release From Human Primary Synoviocytes Costimulated With IL-17 and TNF
    Huppertz, Christine
    Djuric, Marija Curcic
    Hennze, Robert
    Kolbinger, Frank
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S407 - S407
  • [37] IL-17 Antibody Therapy in Pembrolizumab-induced Psoriasis
    Koett, J.
    Gebhardt, C.
    Schneider, S. W.
    Booken, N.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 83 - 84
  • [38] Negative association between autoantibodies against IL-17, IL-17/anti-IL-17 antibody immune complexes and destruction in rheumatoid arthritis
    Ndongo-Thiam, Ndieme
    Clement, Alice
    Pin, Jean-Jacques
    Razanajaona-Doll, Diane
    Miossec, Pierre
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (07) : 1420 - U217
  • [39] IL-17 Induces Inflammation-Associated Gene Products in Blood Monocytes, and Treatment with Ixekizumab Reduces Their Expression in Psoriasis Patient Blood
    Wang, Claire Q. F.
    Suarez-Farinas, Mayte
    Nograles, Kristine E.
    Mimoso, Claudia A.
    Shrom, David
    Dow, Ernst R.
    Heffernan, Michael P.
    Hoffman, Robert W.
    Krueger, James G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (12) : 2990 - 2993
  • [40] First-in-human study demonstrating the safety and clinical efficacy of novel anti-IL-17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis
    Kaul, M.
    Jarvis, P.
    Rozenberg, I
    Kolbinger, F.
    Di Padova, F.
    Calonder, C.
    Espie, P.
    Rondeau, J. M.
    Cebe, R.
    Huber, T.
    Mussmann, R.
    Aassi, M.
    Sligh, T. S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (05) : 1143 - 1151
12345